Melinta down 12% premarket on EPS miss [Seeking Alpha]
MELINTA THERAPEUTICS INC (MLNT)
Last melinta therapeutics inc earnings: 11/12 04:39 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.melinta.com/investor-relations
Company Research
Source: Seeking Alpha
Melinta Therapeutics ( MLNT ) Q2 results : Revenues: $16M (+33.3%); Product sales: $13.8M (+50.0%); Contract research: $2.1M (-27.6%). Net Loss: ($36.2M) (+35.1%); loss/share: ($3.07) (+55.6%); Quick Assets: $90.3M (+10.4%). CF Ops: ($63M) (+40.4%). The Company is not providing any financial guidance for FY 2019. Key 2019 milestones : FDA approval for Baxdela for the treatment of CABP in adults by October 24, 2019. European Commission approval decision for delafloxacin (to be marketed under the brand name Quofenix) for ABSSSI. Country approvals for Baxdela in South America and Central America. Shares are down premarket. Previously: Melinta Therapeutics EPS misses by $0.48, beats on revenue (Aug. 9) See all stocks on the move » Now read: Melinta Gains Speedy Review For Expanded Application » Subscribe for full text news in your inbox
Show less
Read more
Impact Snapshot
Event Time:
MLNT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLNT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLNT alerts
High impacting MELINTA THERAPEUTICS INC news events
Weekly update
A roundup of the hottest topics